Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?

被引：0
作者：
Luciano F. Drager
Andrea Pio-Abreu
Renato D. Lopes
Luiz A. Bortolotto
机构：
[1] University of São Paulo Medical School,Hypertension Unit, Renal Division
[2] University of Sao Paulo Medical School,Hypertension Unit, Heart Institute (InCor)
[3] Duke University Medical Center,Duke Clinical Research Institute
来源：
Current Hypertension Reports | 2020年 / 22卷
关键词：
Hypertension; COVID-19; Prognosis; Treatment; Outcomes; RAS inhibition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 250 条
[21]  
Zhang J(2016)The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice J Mol Cell Cardiol 97 180-undefined
[22]  
Wang B(2009)Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan Am J Physiol Renal Physiol 296 F398-undefined
[23]  
Xiang H(2017)Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014 Hypertension. 70 736-undefined
[24]  
Cheng Z(2020)Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis Eur Respir J 55 2000547-undefined
[25]  
Xiong Y(2005)Angiotensin-converting enzyme 2 protects from severe acute lung failure Nature. 436 112-undefined
[26]  
Zhao Y(undefined)undefined undefined undefined undefined-undefined
[27]  
Li Y(undefined)undefined undefined undefined undefined-undefined
[28]  
Wang X(undefined)undefined undefined undefined undefined-undefined
[29]  
Peng Z(undefined)undefined undefined undefined undefined-undefined
[30]  
Yang J(undefined)undefined undefined undefined undefined-undefined
12345678910